Navigation Links
Financial Results, Appointments, Earnings Conferences, and Partnerships - Research Report on New Oriental Education & Technology, Acacia Research, DeVry, Capella Education, and Qiagen NV
Date:7/26/2013

NEW YORK, July 26, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting New Oriental Education & Technology Group (NYSE: EDU), Acacia Research Corporation (NASDAQ: ACTG), DeVry, Inc. (NYSE: DV), Capella Education Co. (NASDAQ: ACTG), and Qiagen NV (NASDAQ: QGEN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

New Oriental Education & Technology Group Research Report

On July 23, 2013, New Oriental Education & Technology Group (EDU) released the Company's unaudited financial results for Q4 FY 2013 and full-year FY 2013 (period ended May 31, 2013). Total net revenues for Q4 FY 2013 increased 26.6% YoY to $239.6 million. Louis T. Hsieh, New Oriental's President and Chief Financial Officer, said, "In the full fiscal year 2013, we recorded total net revenues of US$959.9 million, representing a 27.4% increase year-over-year. Our overseas test preparation and overseas study consulting businesses recorded combined year-over-year gross revenue growth of about 28% to approximately US$350 million during the fiscal year, while our K-12 all-subjects after-school tutoring business recorded year-over-year gross revenue growth of about 40% to approximately US$411 million in fiscal year 2013." The Full Research Report on New Oriental Education & Technology Group - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-07-24/EDU ]

Acacia Research Corporation Research Report

On July 23, 2013, Acacia Research Corporation (Acacia) appointed Mr. Hiro Seki as Senior Vice President for Acacia Research Group LLC. Mr. Seki will lead all of Acacia's business development and related work in Asia.  Mr. Seki said, "I am very excited to be joining Acacia. I have been working closely with the Acacia team for the past few years while at Renesas. During that time, we at Renesas saw the tremendous benefits Acacia brought to our company. I have joined Acacia because I would like to see other patent holders realize similar benefits from Acacia's patent licensing expertise." Matthew Vella, President of Acacia, added, "Hiro's extensive experience in managing intellectual property at a leading Japanese technology company, and particularly his experience originating and running successful globally-scoped patent licensing programs, makes him uniquely qualified to enable Acacia to become a significant participant in Asian patent markets." The Full Research Report on Acacia Research Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-07-24/ACTG ]

DeVry, Inc. Research Report

On July 22, 2013, DeVry, Inc. (DeVry) announced that the Company will host a conference call on August 8, 2013 at 4:00 p.m. CDT (5:00 p.m. EDT) to review its FY 2013 financial results. DeVry reported that the call will be led by Daniel Hamburger, President and Chief Executive Officer, Tim Wiggins, Chief Financial Officer, and Pat Unzicker, Vice President of Finance. The Company will also host a live online broadcast of the call. The Company informed that the webcast will be made available to users via the Investor Relations section of DeVry's website. The Full Research Report on DeVry, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-07-24/DV ]

Capella Education Co. Research Report

On July 12, 2013, Capella University, an accredited online university, along with the American Nurses Association (ANA), signed an agreement that will focus on developing programs and offerings for the ANA Leadership Institute to advance the preparation and education of nurse leaders. The ANA has agreed to a corresponding agreement with The Ohio State University College of Nursing. Marla Weston, PhD, RN, FAAN, CEO of the ANA, commented, "With these two partner organizations, we are able to build on ANA's rich tradition of excellence through the competency-based approach combined with the technology and online learning platform of Capella University. Along with the faculty reputation and evidence-based instruction of The Ohio State University College of Nursing, this will allow us to enrich the learning experience of programs offered through our ANA Leadership Institute." The Full Research Report on Capella Education Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-07-24/CPLA ]

Qiagen NV Research Report

On July 23, 2013, Qiagen NV (Qiagen) announced its partnership with Exosome Diagnostics Inc. (Exosome Diagnostics) with an aim to develop and commercialize high-performance sample preparation kits for the processing of nucleic acids from exosomes. Dirk Loeffert, Vice President Global Product Development Life Sciences of QIAGEN, commented, "QIAGEN is a global leader in personalized healthcare solutions, and Exosome Diagnostics is a leading developer in biofluid-based molecular testing. We believe QIAGEN can bring to market the first comprehensive line of products to help researchers and pharmaceutical companies explore and monitor disease status using fresh or frozen biofluids, addressing the critical challenge of access to samples. We also intend to co-develop exosome-based workflows for routine use in personalized healthcare, a revolutionary improvement compared to today's widespread dependence on tissue biopsies, offering the ability to create a new dimension of utility for our molecular testing assay portfolio." The Full Research Report on Qiagen NV - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-07-24/QGEN ]

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


'/>"/>
SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
7. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Lexicon to Provide First Quarter 2012 Financial Results
10. Chindex International, Inc. to Report First Quarter 2012 Financial Results
11. Anthera Announces First Quarter 2012 Financial Report and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):